Clinical activity of the EGFR tyrosine kinase inhibitor osimertinib in EGFR-mutant glioblastoma
暂无分享，去创建一个
Zev A. Binder | Hongjun Song | S. Brem | D. O’Rourke | J. Dorsey | M. Nasrallah | Fadi Jacob | J. Morrissette | Ryan D. Salinas | S. Bagley | A. Desai | I. Makhlin | Daniel Y. Zhang | Deeksha Saxena | Daniel Y Zhang | Gou-Li Ming